These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 10321415)

  • 1. Safety profile of sustained-release bupropion in depression: results of three clinical trials.
    Settle EC; Stahl SM; Batey SR; Johnston JA; Ascher JA
    Clin Ther; 1999 Mar; 21(3):454-63. PubMed ID: 10321415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients.
    Reimherr FW; Cunningham LA; Batey SR; Johnston JA; Ascher JA
    Clin Ther; 1998; 20(3):505-16. PubMed ID: 9663366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment.
    Segraves RT; Kavoussi R; Hughes AR; Batey SR; Johnston JA; Donahue R; Ascher JA
    J Clin Psychopharmacol; 2000 Apr; 20(2):122-8. PubMed ID: 10770448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
    Croft H; Settle E; Houser T; Batey SR; Donahue RM; Ascher JA
    Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
    Weihs KL; Settle EC; Batey SR; Houser TL; Donahue RM; Ascher JA
    J Clin Psychiatry; 2000 Mar; 61(3):196-202. PubMed ID: 10817105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
    Kavoussi RJ; Segraves RT; Hughes AR; Ascher JA; Johnston JA
    J Clin Psychiatry; 1997 Dec; 58(12):532-7. PubMed ID: 9448656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks.
    Croft H; Houser TL; Jamerson BD; Leadbetter R; Bolden-Watson C; Donahue R; Metz A
    Clin Ther; 2002 Apr; 24(4):662-72. PubMed ID: 12017410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of sustained-release bupropion and placebo for smoking cessation.
    Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
    N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.
    Coleman CC; King BR; Bolden-Watson C; Book MJ; Segraves RT; Richard N; Ascher J; Batey S; Jamerson B; Metz A
    Clin Ther; 2001 Jul; 23(7):1040-58. PubMed ID: 11519769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and safety of sustained-release bupropion in the management of smoking cessation.
    Aubin HJ
    Drugs; 2002; 62 Suppl 2():45-52. PubMed ID: 12109935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment.
    Coleman CC; Cunningham LA; Foster VJ; Batey SR; Donahue RM; Houser TL; Ascher JA
    Ann Clin Psychiatry; 1999 Dec; 11(4):205-15. PubMed ID: 10596735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective safety surveillance study for bupropion sustained-release in the treatment of depression.
    Dunner DL; Zisook S; Billow AA; Batey SR; Johnston JA; Ascher JA
    J Clin Psychiatry; 1998 Jul; 59(7):366-73. PubMed ID: 9714265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of sustained-release bupropion in neuropathic pain: an open-label study.
    Semenchuk MR; Davis B
    Clin J Pain; 2000 Mar; 16(1):6-11. PubMed ID: 10741812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study.
    Jefferson JW; Rush AJ; Nelson JC; VanMeter SA; Krishen A; Hampton KD; Wightman DS; Modell JG
    J Clin Psychiatry; 2006 Jun; 67(6):865-73. PubMed ID: 16848645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion sustained release: side effect profile.
    Settle EC
    J Clin Psychiatry; 1998; 59 Suppl 4():32-6. PubMed ID: 9554319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression.
    Weihs KL; Houser TL; Batey SR; Ascher JA; Bolden-Watson C; Donahue RM; Metz A
    Biol Psychiatry; 2002 May; 51(9):753-61. PubMed ID: 11983189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.
    Jain AK; Kaplan RA; Gadde KM; Wadden TA; Allison DB; Brewer ER; Leadbetter RA; Richard N; Haight B; Jamerson BD; Buaron KS; Metz A
    Obes Res; 2002 Oct; 10(10):1049-56. PubMed ID: 12376586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain.
    Semenchuk MR; Sherman S; Davis B
    Neurology; 2001 Nov; 57(9):1583-8. PubMed ID: 11706096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.